These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 37505274)

  • 1. A meta-analysis evaluating efficacy and safety of colchicine for prevention of major cardiovascular events in patients with coronary artery disease.
    Chen T; Liu G; Yu B
    Clin Res Cardiol; 2023 Nov; 112(11):1487-1505. PubMed ID: 37505274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colchicine may become a new cornerstone therapy for coronary artery disease: a meta-analysis of randomized controlled trials.
    Chen Y; Zhang H; Chen Y; Li M; Luo W; Liu Y; Fu Y; Xia H; Xu C; Jiang Y; Wu Y
    Clin Rheumatol; 2022 Jun; 41(6):1873-1887. PubMed ID: 35138464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Colchicine in Patients with Stable CAD and ACS: A Systematic Review and Meta-analysis.
    Ullah W; Haq S; Zahid S; Gowda SN; Ottman P; Saleem S; Hamzeh I; Virani SS; Alam M; Fischman DL
    Am J Cardiovasc Drugs; 2021 Nov; 21(6):659-668. PubMed ID: 34151410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of colchicine for the prevention of major cardiovascular and cerebrovascular events in patients with coronary artery disease: a systematic review and meta-analysis on 12 869 patients.
    Andreis A; Imazio M; Piroli F; Avondo S; Casula M; Paneva E; De Ferrari GM
    Eur J Prev Cardiol; 2022 Feb; 28(17):1916-1925. PubMed ID: 33779702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colchicine for Secondary Prevention of Coronary Artery Disease: A Meta-Analysis of Randomised Controlled Trials.
    Xu H; Mao L; Liu H; Lin Z; Zhang Y; Yang J
    Heart Lung Circ; 2022 May; 31(5):685-695. PubMed ID: 35033433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis.
    Ullah W; Gowda SN; Fischman D
    Cardiovasc Revasc Med; 2021 Feb; 23():1-6. PubMed ID: 32553442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of colchicine for secondary prevention of coronary heart disease: a systematic review and meta-analysis.
    Xiang Z; Yang J; Yang J; Zhang J; Fan Z; Yang C; Di L; Ma C; Wu J; Huang Y
    Intern Emerg Med; 2021 Mar; 16(2):487-496. PubMed ID: 33400158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary Syndromes.
    Ramanathan K; Abel JG; Park JE; Fung A; Mathew V; Taylor CM; Mancini GBJ; Gao M; Ding L; Verma S; Humphries KH; Farkouh ME
    J Am Coll Cardiol; 2017 Dec; 70(24):2995-3006. PubMed ID: 29241487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.
    Palmerini T; Serruys P; Kappetein AP; Genereux P; Riva DD; Reggiani LB; Christiansen EH; Holm NR; Thuesen L; Makikallio T; Morice MC; Ahn JM; Park SJ; Thiele H; Boudriot E; Sabatino M; Romanello M; Biondi-Zoccai G; Cavalcante R; Sabik JF; Stone GW
    Am Heart J; 2017 Aug; 190():54-63. PubMed ID: 28760214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease.
    Garg A; Rao SV; Agrawal S; Theodoropoulos K; Mennuni M; Sharma A; Garg L; Ferrante G; Meelu OA; Sargsyan D; Reimers B; Cohen M; Kostis JB; Stefanini GG
    Am J Cardiol; 2017 Jun; 119(12):1942-1948. PubMed ID: 28433215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.
    Deb S; Wijeysundera HC; Ko DT; Tsubota H; Hill S; Fremes SE
    JAMA; 2013 Nov; 310(19):2086-95. PubMed ID: 24240936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis Evaluating the Utility of Colchicine in Secondary Prevention of Coronary Artery Disease.
    Xia M; Yang X; Qian C
    Am J Cardiol; 2021 Feb; 140():33-38. PubMed ID: 33137319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial.
    Akrami M; Izadpanah P; Bazrafshan M; Hatamipour U; Nouraein N; Drissi HB; Manafi A
    BMC Cardiovasc Disord; 2021 Dec; 21(1):583. PubMed ID: 34876021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of multivessel percutaneous coronary intervention and coronary artery bypass grafting in patients with severe coronary artery disease presenting with non-ST-segment elevation acute coronary syndromes.
    Desperak P; Hawranek M; Hrapkowicz T; Zembala MO; Gąsior M
    Kardiol Pol; 2018; 76(10):1474-1481. PubMed ID: 30251246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis.
    Sabatine MS; Bergmark BA; Murphy SA; O'Gara PT; Smith PK; Serruys PW; Kappetein AP; Park SJ; Park DW; Christiansen EH; Holm NR; Nielsen PH; Stone GW; Sabik JF; Braunwald E
    Lancet; 2021 Dec; 398(10318):2247-2257. PubMed ID: 34793745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug repurposing? Cardiovascular effect of colchicine on patients with coronary artery disease: A systematic review and meta-analysis.
    Tien YY; Huang HK; Shih MC; Tu YK
    J Cardiol; 2021 Jun; 77(6):576-582. PubMed ID: 33272780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of the effect of colchicine on C-reactive protein in patients with acute and chronic coronary syndromes.
    Alam M; Kontopantelis E; Mamas MA; Savinova OV; Jhaveri A; Siddiqui E; Jhamnani S
    Coron Artery Dis; 2023 May; 34(3):210-215. PubMed ID: 36762630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid Coronary Revascularization vs Complete Coronary Artery Bypass Grafting for Multivessel Coronary Artery Disease: A Systematic Review and Meta-Analysis.
    Nolan S; Filion KB; Atallah R; Moss E; Reynier P; Eisenberg MJ
    J Invasive Cardiol; 2018 Dec; 30(12):E131-E149. PubMed ID: 30504516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Trials.
    Kofler T; Kurmann R; Lehnick D; Cioffi GM; Chandran S; Attinger-Toller A; Toggweiler S; Kobza R; Moccetti F; Cuculi F; Jolly SS; Bossard M
    J Am Heart Assoc; 2021 Aug; 10(16):e021198. PubMed ID: 34369166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-Guided Antiplatelet Therapy Versus Standard Therapy for Patients with Coronary Artery Disease: An Updated Systematic Review and Meta-Analysis.
    Tang B; Wang X; Wang X; Liu L; Ma Z
    J Pharm Pharm Sci; 2022; 25():9-23. PubMed ID: 34995471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.